HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tongalp H Tezel Selected Research

Wet Macular Degeneration

1/2007Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.
3/2003Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tongalp H Tezel Research Topics

Disease

6Macular Degeneration (Age-Related Maculopathy)
12/2018 - 01/2007
4Macular Edema
01/2020 - 04/2007
3Retinitis Pigmentosa (Pigmentary Retinopathy)
10/2021 - 02/2003
3Neoplasms (Cancer)
08/2019 - 03/2003
3Choroidal Neovascularization
04/2007 - 03/2003
2Glaucoma
01/2021 - 01/2018
2Neoplasm Metastasis (Metastasis)
08/2019 - 01/2018
2Geographic Atrophy
12/2018 - 11/2006
2Inflammation (Inflammations)
04/2007 - 01/2007
2Wet Macular Degeneration
01/2007 - 03/2003
1Retinal Degeneration
10/2021
1Atrophy
01/2021
1COVID-19
01/2021
1Retinal Detachment (Retinal Detachments)
01/2021
1Edema (Dropsy)
01/2020
1Cysts
01/2020
1Breast Neoplasms (Breast Cancer)
08/2019
1Eye Diseases (Eye Disease)
12/2018
1Carcinoma (Carcinomatosis)
01/2018
1Angle-Closure Glaucoma (Glaucoma, Angle Closure)
01/2018
1Polypoidal Choroidal Vasculopathy
11/2016
1Aphakia
09/2012
1Retinal Perforations
01/2012
1Infections
01/2012
1Wounds and Injuries (Trauma)
08/2011
1Hypoxia (Hypoxemia)
04/2009
1Diabetic Retinopathy (Retinopathy, Diabetic)
04/2009
1Anterior Uveitis
01/2007
1Retinal Neovascularization
12/2005
1Rupture
12/2005
1Gliosis
12/2005
1Diplopia (Double Vision)
02/2003
1Cataract (Cataracts)
02/2003

Drug/Important Bio-Agent (IBA)

8Retinaldehyde (Retinal)IBA
10/2021 - 02/2003
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 11/2006
3Bevacizumab (Avastin)FDA Link
08/2019 - 12/2008
3Triamcinolone (Aristocort)FDA Link
08/2016 - 12/2008
2Fluorescein (Funduscein)FDA LinkGeneric
08/2019 - 04/2007
2Endothelial Growth FactorsIBA
01/2018 - 01/2012
1CytokinesIBA
10/2021
1Neuroprotective AgentsIBA
10/2021
1Viral RNAIBA
01/2021
1SolutionsIBA
08/2019
1VitaminsIBA
12/2018
1AntioxidantsIBA
12/2018
1Acetazolamide (Diamox)FDA LinkGeneric
08/2016
1Silicone OilsIBA
09/2012
1Hemoglobins (Hemoglobin)IBA
04/2009
1Biological ProductsIBA
12/2008
1Acetates (Acetic Acid Esters)FDA Link
12/2008
1Retinal Pigments (Pigments, Visual)IBA
04/2007
1Proteins (Proteins, Gene)FDA Link
01/2007
1Thromboplastin (Tissue Factor)IBA
01/2007
1Factor VII (Proconvertin)IBA
01/2007
1Complement System Proteins (Complement)IBA
01/2007
1XenonIBA
12/2005

Therapy/Procedure

3Transplantation
10/2021 - 02/2003
3Drug Therapy (Chemotherapy)
08/2019 - 12/2008
3Injections
08/2019 - 12/2008
2Cell Transplantation
10/2021 - 04/2007
2Intravitreal Injections
08/2019 - 01/2012
2Light Coagulation
01/2007 - 12/2005
2Immunotherapy
01/2007 - 03/2003
2Lasers (Laser)
01/2007 - 03/2003
1Radical Mastectomy
08/2019
1Brachytherapy
08/2019
1Radiotherapy
08/2019
1Therapeutics
12/2018
1Sutures (Suture)
09/2012
1Surgical Instruments (Clip)
08/2011
1Semiconductor Lasers
12/2005
1Debridement
12/2005